The First Crispr Treatment Is Making Its Way to Patients
It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.
Where Will CRISPR Therapeutics Be in 3 Years?
CRISPR Therapeutics (NASDAQ: CRSP) made a name for itself by pioneering advanced gene therapies made with technologies that ...
Singularity Hub21h
Sweet CRISPR Tomatoes May Be Coming to a Supermarket Near You
Using CRISPR, the popular gene-editing tool, scientists bumped up the fruit’s sugar content by 30 percent without sacrificing ...
Is it ever OK for scientists to experiment on themselves?
Ethicists often debate how to understand reasonable risk. But it is widely agreed that reasonable risks must be minimised to ...
Cathie Wood’s ARK Investment bought 178.1K shares of Crispr Therapeutics today
EST Cathie Wood’s ARK Investment bought 178.1K shares of Crispr Therapeutics (CRSP) today Published first on TheFly – the ...
Gene Editing Market to Hit USD 7.59 Billion by 2029 with 10.2% CAGR | MarketsandMarkets™
The global gene editing market is expected to reach USD 7.59 billion in 2029 from USD 4.66 billion in 2024, at a CAGR of 10.2 ...
Nature1h
How human brains got so big: our cells learned to handle the stress that comes with size
Understanding how human neurons cope with the energy demands of a large, active brain could open up new avenues for treating ...
Chinese scientists modify tomatoes to make them ‘significantly sweeter’
Glucose and fructose levels were 30 per cent higher after researchers removed two genes that regulate sugar content, ...
Buy Rating for Caribou Biosciences Backed by Strong Financial Position and Strategic Growth Catalysts
In a report released today, Robert Burns from H.C. Wainwright reiterated a Buy rating on Caribou Biosciences (CRBU – Research Report), ...
labiotech6h
How biotech startups become unicorns
A biotech startup’s journey to unicorn status hinges on its leadership and the culture fostered within the organization. A ...
Science Daily42m
Exposure to marijuana in the womb may increase risk of addiction to opioids later in life, study finds
Evidence has been growing to suggest that tetrahydrocannabinol (THC), the main psychoactive ingredient in cannabis, poses risks to the developing fetus by impacting brain development. Now a new ...